Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients:: A prospective study

被引:70
作者
Jouet, Pauline
Sabate, Jean-Marc
Maillard, Dominique
Msika, Simon
Mechler, Charlotte
Ledoux, Severine
Harnois, Florence
Coffin, Benoit
机构
[1] Hop Louis Mourier, AP HP, Serv Hepatogastroenterol, F-92701 Colombes, France
[2] Hop Louis Mourier, AP HP, Serv Explorat Fonct, F-92701 Colombes, France
[3] Hop Louis Mourier, AP HP, Serv Chirurg Viscerale, F-92701 Colombes, France
[4] Hop Louis Mourier, AP HP, Serv Anatomopathol, F-92701 Colombes, France
关键词
non-alcoholic steatohepatitis; steatosis; morbid obesity; surgery;
D O I
10.1007/s11695-007-9085-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Morbid obesity is a risk factor of nonalcoholic steatohepatitis (NASH). Obstructive sleep apnea (OSA) could also be an independent risk factor for elevated liver enzymes and NASH. The relationships between liver injuries and OSA in morbidly obese patients requiring bariatric surgery were studied prospectively. Methods: Every consecutive morbidly obese patient (BMI >= 40 kg/m(2) or >= 35 kg/m(2) with severe comorbidities) requiring bariatric surgery was included between January 2003 and October 2004. Polygraphic recording, serum aminotransferases (ALT, AST), gamma-glutamyltransferase (GGT) and liver biopsy were systematically performed. OSA was present when the apnea-hypopnea index (AHI) was > 10/h. Results: 62 patients (54 F; age 38.5 > 11.0 (SD) yrs; BMI 47.8 +/- 8.4 kg/m(2)) were included. Liver enzymes (AST, ALT or GGT) were increased in 46.6%. NASH was present in 34.4% and OSA in 84.7%. Patients with OSA were significantly older (P = 0.015) and had a higher BMI (P = 0.003). In multivariate analysis, risk factors for elevated liver enzymes were the presence of OSA and male sex. The presence of NASH was similar in patients with or without OSA (32.7% vs 44.4% of patients, P = 0.76). Conclusion: In this cohort of morbidly obese patients requiring bariatric surgery, one-third of patients had NASH, a prevalence similar to previous studies. OSA was found to be a risk factor for elevated liver enzymes but not for NASH.
引用
收藏
页码:478 / 485
页数:8
相关论文
共 39 条
[1]   Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]   Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery [J].
Beymer, C ;
Kowdley, KV ;
Larson, A ;
Edmonson, P ;
Dellinger, EP ;
Flum, DR .
ARCHIVES OF SURGERY, 2003, 138 (11) :1240-1244
[4]   Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass [J].
Boza, C ;
Riquelme, A ;
Ibañez, L ;
Duarte, I ;
Norero, E ;
Viviani, P ;
Soza, A ;
Fernandez, JI ;
Raddatz, A ;
Guzman, S ;
Arrese, M .
OBESITY SURGERY, 2005, 15 (08) :1148-1153
[5]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[6]   Obstructive sleep apnea [J].
Caples, SM ;
Gami, AS ;
Somers, VK .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (03) :187-197
[7]   Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury [J].
Caraceni, P ;
Ryu, HS ;
Subbotin, V ;
DeMaria, N ;
Colantoni, A ;
Roberts, L ;
Trevisani, F ;
Bernardi, M ;
VanTheil, DH .
HEPATOLOGY, 1997, 25 (04) :943-949
[8]   Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients [J].
Chin, K ;
Nakamura, T ;
Takahashi, K ;
Sumi, K ;
Ogawa, Y ;
Masuzaki, H ;
Muro, S ;
Hattori, N ;
Matsumoto, H ;
Niimi, A ;
Chiba, T ;
Nakao, K ;
Mishima, M ;
Ohi, M ;
Nakamura, T .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (05) :370-376
[9]   NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497